Results 141 to 150 of about 1,574,974 (310)

Volume 54, Issue 1 - Monday, September 10, 2018 [PDF]

open access: yes, 2018
The Rose Thorn, Rose-Hulman\u27s independent student newspaper.https://scholar.rose-hulman.edu/rosethorn/2197/thumbnail ...
Rose Thorn Staff,
core  

The Effect of Inhalation Aromatherapy With Damask Rose (Rosa Damascena) on the Pain of Elderly After Knee Arthroplasty

open access: yesJournal of Client-centered Nursing Care, 2017
Background: Acute postoperative pain is anticipated as a common problem in orthopedic surgeries especially arthroplasty which can cause harmful effects to the body and the psyche of the person.
Farideh Bastani   +2 more
doaj  

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay   +15 more
wiley   +1 more source

Volume 27 - Issue 7 - Friday, October 18, 1991 [PDF]

open access: yes, 1991
The Rose Thorn, Rose-Hulman\u27s independent student newspaper.https://scholar.rose-hulman.edu/rosethorn/1607/thumbnail ...
Rose Thorn Staff,
core  

Troponin T and Neurofilament Light Chain Levels as Complementary Biomarkers of Disease Accumulation and Aggressiveness in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is a clinically heterogeneous neurodegenerative disease requiring reliable biomarkers to improve patient stratification and trial design. While serum neurofilament light chain (sNfL) reflects neuroaxonal stress and disease aggressiveness, troponin T (TnT) may capture complementary aspects of ...
Julia Sellin   +8 more
wiley   +1 more source

Volume 9- Issue 3- Friday, September 28, 1973 [PDF]

open access: yes, 1973
The Rose Thorn, Rose-Hulman\u27s independent student newspaper.https://scholar.rose-hulman.edu/rosethorn/2025/thumbnail ...
Rose Thorn Staff,
core  

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son   +3 more
wiley   +1 more source

Volume 3- Issue 8- May, 1894 [PDF]

open access: yes, 1894
The Rose Thorn, Rose-Hulman\u27s independent student newspaper.https://scholar.rose-hulman.edu/rosethorn/2137/thumbnail ...
Rose Thorn Staff,
core  

White Matter and Perivascular Imaging Changes in Alzheimer's Disease and Cerebral Amyloid Angiopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Peak‐width of skeletonized mean diffusivity (PSMD) and diffusion tensor imaging–analysis along the perivascular space (DTI‐ALPS), reflecting white matter integrity and glymphatic function, are altered in Alzheimer's disease (AD).
Debina Laishram   +3 more
wiley   +1 more source

Modeling Progressive Brain Volume Losses in Chronic Moderate Severe Traumatic Brain Injury: Extensive, but Attenuating

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progressive brain atrophy has now been widely observed in the chronic stages of moderate–severe traumatic brain injury (msTBI), but there is only coarse information regarding its prevalence and magnitude, and whether rate of atrophy accelerates or attenuates across time. We examined these questions in a Canadian inception cohort from
Robin E. A. Green   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy